Revolution Medicines

Filed a patent for "use of sos1 inhibitors to treat malignancies with shp2 mutations" on Thu, February 1, 2024

Filed a patent for "ras inhibitors" on Fri, June 30, 2023

Filed a patent for "methods and reagents for analyzing protein-protein interfaces" on Thu, December 26, 2024

Filed a patent for "compositions for inducing ras gtp hydrolysis and uses thereof in combination with ras(off) inhibitors" on Thu, March 30, 2023

Filed a patent for "ras inhibitors" on Fri, April 7, 2023

Filed a patent for "ras inhibitors" on Fri, April 7, 2023

Filed a patent for "ras inhibitors" on Fri, May 26, 2023

Filed a patent for "compositions for inducing ras gtp hydrolysis and uses thereof" on Fri, July 21, 2023

Filed a patent for "ras inhibitors" on Mon, December 18, 2023

Filed a patent for "ras inhibitors" on Tue, January 23, 2024

Filed a patent for "synthesis of ras inhibitors" on Fri, April 14, 2023

Filed a patent for "crystalline forms of ras inhibitors, compositions containing the same, and methods of use thereof" on Fri, April 14, 2023

Filed a patent for "synthesis of ras inhibitors" on Fri, April 14, 2023

Filed a patent for "crystalline forms of ras inhibitors, compositions containing the same, and methods of use thereof" on Fri, April 14, 2023

Filed a patent for "use of sos1 inhibitors with mtor inhibitors to treat cancers" on Thu, November 9, 2023

Filed a patent for "ras inhibitors" on Thu, September 28, 2023

Filed a patent for "bicyclic heteroaryl compounds and uses thereof" on Thu, November 16, 2023

Filed a patent for "methods for treating cancer" on Wed, October 12, 2022

Filed a patent for "compounds, complexes, and methods for their preparation and of their use" on Wed, November 9, 2022

Filed a patent for "pyrazolopyrazine compounds as shp2 inhibitors" on Thu, December 8, 2022

Filed a patent for "methods for delaying, preventing, and treating acquired resistance to ras inhibitors" on Thu, July 27, 2023

Filed a patent for "ras inhibitors" on Thu, July 27, 2023

Filed a patent for "ras inhibitors" on Thu, November 23, 2023

Filed a patent for "shp2 inhibitor compositions and methods for treating cancer" on Thu, February 22, 2024

Filed a patent for "polycyclic compounds as allosteric shp2 inhibitors" on Thu, March 28, 2024